AI Helps Predict Ulcerative Colitis Remission/Activity, Flare-ups

An AI tool can distinguish histological remission from activity in biopsies of UC and predict flare-ups -- and could have a role in both clinical trials and routine practice.

Related Keywords

New York ,United States ,Ireland ,Marietta Iacucci ,David Hudesman ,Langone Health ,University College Cork ,Inflammatory Bowel Disease Center ,University Of Birmingham ,Medscape Medical ,Robarts Histopathology Index ,Nancy Histological Index ,Remission Index ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Artificial Intelligence ,A I ,Hi ,Ulcerative Colitis ,Biopsy ,Inflammatory Bowel Disease ,Nflammatory Bowel Disease Ibd ,Bd ,Colitis ,Remission ,Clinical Research ,Clinical Trials ,Linical Studies ,Histology ,Endoscopy ,